AGENDA:

Drug Utilization Review Board

Feb. 25, 2010
10 a.m.

Meeting Site:
Texas Department of Aging and Disability Services
Winters Building
Public Hearing Room
701 W. 51st St.
Austin

1. Call to Order

2. Approval of Minutes from Oct. 29, 2009

3. Retrospective Drug Utilization Review Interventions (Action Items): – Robert Berringer, Pharm.D., R.Ph
   • Hyperlipidemics-Appropriate Use
   • Anticonvulsants: Drug Usage Evaluation
   • Brand-Generic Conversions
     
     
4. Prospective Prior Authorization Proposals (Clinical Edits): (Action Items) – Robert Berringer, Pharm.D., R.Ph
   • Orapred Orally Disintegrating Tablets (prednisolone sodium phosphate)
   • Anticonvulsant Agent (gabapentin) - Revision to existing edit
   • Exenatide Injection (Byetta) - Revision to existing edit
     
     
5. Retrospective Drug Use Criteria for Outpatient Use in the Vendor Drug Program (Action Items) - Jennifer Seltzer, Pharm.D.
   • Acetylcholinesterase Inhibitors
   • Pramlintide (Symlin)
   • Exenatide (Byetta)
     
     
6. Metanx Review - Marc Fluitt, Pamlab L.L.C.

7. Prolacta Review – Scott Eaker, Prolacta Bioscience
   
   
8. Public Comment
   
   * Public comment will be taken following each item, after staff presentation and/or before a vote on the action item
   
   
9. Schedule next meeting – June 3, 2010
   
   
10. Adjourn

• Public comment will be taken following each item, after staff presentation and/or before a vote on the action item.

Contact: Amanda Fay, Medicaid/CHIP Division, 512-491-4012, Amanda.Fay@hhsc.state.tx.us.

This meeting is open to the public. No reservations are required and there is no cost to attend this meeting.

People with disabilities who wish to attend the meeting and require auxiliary aids or services should contact Fay at 512-491-4012 at least 72 hours before the meeting so appropriate arrangements can be made.